These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
429 related articles for article (PubMed ID: 31118110)
21. Regional pattern of microgliosis in sporadic Creutzfeldt-Jakob disease in relation to phenotypic variants and disease progression. Franceschini A; Strammiello R; Capellari S; Giese A; Parchi P Neuropathol Appl Neurobiol; 2018 Oct; 44(6):574-589. PubMed ID: 29345730 [TBL] [Abstract][Full Text] [Related]
22. Cell adhesion molecule CD44 is dispensable for reactive astrocyte activation during prion disease. Bradford BM; Walmsley-Rowe L; Reynolds J; Verity N; Mabbott NA Sci Rep; 2024 Jun; 14(1):13749. PubMed ID: 38877012 [TBL] [Abstract][Full Text] [Related]
23. Glial alterations in human prion diseases: A correlative study of astroglia, reactive microglia, protein deposition, and neuropathological lesions. Monzón M; Hernández RS; Garcés M; Sarasa R; Badiola JJ Medicine (Baltimore); 2018 Apr; 97(15):e0320. PubMed ID: 29642165 [TBL] [Abstract][Full Text] [Related]
24. Phagocytic Activities of Reactive Microglia and Astrocytes Associated with Prion Diseases Are Dysregulated in Opposite Directions. Sinha A; Kushwaha R; Molesworth K; Mychko O; Makarava N; Baskakov IV Cells; 2021 Jul; 10(7):. PubMed ID: 34359897 [TBL] [Abstract][Full Text] [Related]
25. Enhanced M-CSF/CSF1R Signaling Closely Associates with PrP Xia Y; Chen C; Chen J; Hu C; Yang W; Wang L; Liu L; Gao LP; Wu YZ; Chen DD; Shi Q; Chen ZB; Dong XP Mol Neurobiol; 2022 Oct; 59(10):6534-6551. PubMed ID: 35970974 [TBL] [Abstract][Full Text] [Related]
26. The role of the NADPH oxidase NOX2 in prion pathogenesis. Sorce S; Nuvolone M; Keller A; Falsig J; Varol A; Schwarz P; Bieri M; Budka H; Aguzzi A PLoS Pathog; 2014 Dec; 10(12):e1004531. PubMed ID: 25502554 [TBL] [Abstract][Full Text] [Related]
27. Stimulations of the Culture Medium of Activated Microglia and TNF-Alpha on a Scrapie-Infected Cell Line Decrease the Cell Viability and Induce Marked Necroptosis That Also Occurs in the Brains from the Patients of Human Prion Diseases. Ma Y; Shi Q; Xiao K; Wang J; Chen C; Gao LP; Gao C; Dong XP ACS Chem Neurosci; 2019 Mar; 10(3):1273-1283. PubMed ID: 30399321 [TBL] [Abstract][Full Text] [Related]
28. A neuroprotective role for microglia in prion diseases. Zhu C; Herrmann US; Falsig J; Abakumova I; Nuvolone M; Schwarz P; Frauenknecht K; Rushing EJ; Aguzzi A J Exp Med; 2016 May; 213(6):1047-59. PubMed ID: 27185853 [TBL] [Abstract][Full Text] [Related]
29. Prion protein expression differences in microglia and astroglia influence scrapie-induced neurodegeneration in the retina and brain of transgenic mice. Kercher L; Favara C; Striebel JF; LaCasse R; Chesebro B J Virol; 2007 Oct; 81(19):10340-51. PubMed ID: 17652390 [TBL] [Abstract][Full Text] [Related]
30. Antibody-mediated inhibition of integrin α5β1 blocks neurotoxic prion peptide PrP106-126-induced activation of BV2 microglia. Chang J; Yang L; Kouadir M; Peng Y; Zhang S; Shi F; Zhou X; Yin X; Zhao D J Mol Neurosci; 2012 Sep; 48(1):248-52. PubMed ID: 22648512 [TBL] [Abstract][Full Text] [Related]
31. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies. Giese A; Kretzschmar HA Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136 [TBL] [Abstract][Full Text] [Related]
34. Microglia in Prion Diseases: Angels or Demons? Peggion C; Stella R; Lorenzon P; Spisni E; Bertoli A; Massimino ML Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33092220 [TBL] [Abstract][Full Text] [Related]
35. Absence of BBSome function leads to astrocyte reactivity in the brain. Singh M; Garrison JE; Wang K; Sheffield VC Mol Brain; 2019 May; 12(1):48. PubMed ID: 31072410 [TBL] [Abstract][Full Text] [Related]
36. Activation of microglia by retroviral infection correlates with transient clearance of prions from the brain but does not change incubation time. Muth C; Schröck K; Madore C; Hartmann K; Fanek Z; Butovsky O; Glatzel M; Krasemann S Brain Pathol; 2017 Sep; 27(5):590-602. PubMed ID: 27558169 [TBL] [Abstract][Full Text] [Related]
37. Effect of intraventricular infusion of anti-prion protein monoclonal antibodies on disease progression in prion-infected mice. Song CH; Furuoka H; Kim CL; Ogino M; Suzuki A; Hasebe R; Horiuchi M J Gen Virol; 2008 Jun; 89(Pt 6):1533-1544. PubMed ID: 18474571 [TBL] [Abstract][Full Text] [Related]
38. Targeting microglial GLP1R in epilepsy: A novel approach to modulate neuroinflammation and neuronal apoptosis. Zhang K; Yang Z; Yang Z; Du L; Zhou Y; Fu S; Wang X; Liu D; He X Eur J Pharmacol; 2024 Oct; 981():176903. PubMed ID: 39154823 [TBL] [Abstract][Full Text] [Related]
39. The degree of astrocyte activation is predictive of the incubation time to prion disease. Makarava N; Mychko O; Chang JC; Molesworth K; Baskakov IV Acta Neuropathol Commun; 2021 May; 9(1):87. PubMed ID: 33980286 [TBL] [Abstract][Full Text] [Related]